Latest Insider Transactions at Acadia Pharmaceuticals Inc (ACAD)
This section provides a real-time view of insider transactions for Acadia Pharmaceuticals Inc (ACAD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACADIA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACADIA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 19
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,259
-16.14%
|
$164,144
$16.81 P/Share
|
Nov 19
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,073
-17.02%
|
$65,168
$16.81 P/Share
|
Nov 19
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
10,329
-14.26%
|
$165,264
$16.81 P/Share
|
Nov 17
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,826
+14.54%
|
-
|
Nov 17
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,930
+15.39%
|
-
|
Nov 17
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
19,826
+12.86%
|
-
|
Oct 12
2024
|
Adora Ndu |
BUY
Exercise of conversion of derivative security
|
Direct |
4,381
+22.13%
|
-
|
Aug 19
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,733
-18.2%
|
$145,995
$15.28 P/Share
|
Aug 19
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
31,747
-14.54%
|
$476,205
$15.28 P/Share
|
Aug 19
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
9,534
-15.45%
|
$143,010
$15.28 P/Share
|
Aug 16
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,904
+16.0%
|
-
|
Aug 16
2024
|
Stephen Davis CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,115
+13.05%
|
-
|
Aug 16
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Grant, award, or other acquisition
|
Direct |
18,653
+13.78%
|
-
|
Jun 10
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
975
-2.74%
|
$13,650
$14.79 P/Share
|
Jun 08
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,893
+5.06%
|
-
|
May 29
2024
|
Laura Brege |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+24.82%
|
-
|
May 29
2024
|
Daniel B Soland |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+16.1%
|
-
|
May 29
2024
|
Edmund Harrigan |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+20.59%
|
-
|
May 29
2024
|
James M Daly |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+21.25%
|
-
|
May 29
2024
|
Elizabeth A. Garofalo |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+22.81%
|
-
|
May 29
2024
|
Adora Ndu |
BUY
Exercise of conversion of derivative security
|
Direct |
6,652
+37.61%
|
-
|
May 29
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
37,548
+0.28%
|
-
|
May 02
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
11,427
-6.86%
|
$182,832
$16.94 P/Share
|
May 02
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,326
-8.45%
|
$21,216
$16.94 P/Share
|
May 02
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
3,477
-7.62%
|
$55,632
$16.94 P/Share
|
May 02
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,503
-9.85%
|
$56,048
$16.94 P/Share
|
May 01
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,391
+11.84%
|
-
|
May 01
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,596
+14.19%
|
-
|
May 01
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,814
+13.0%
|
-
|
May 01
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,814
+16.08%
|
-
|
Apr 08
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,716
-8.63%
|
$46,172
$17.87 P/Share
|
Apr 08
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,790
-6.2%
|
$30,430
$17.87 P/Share
|
Apr 08
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
2,568
-6.21%
|
$43,656
$17.87 P/Share
|
Apr 08
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
26,574
-8.06%
|
$451,758
$17.87 P/Share
|
Apr 07
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,489
+9.09%
|
-
|
Apr 05
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,275
+14.36%
|
-
|
Apr 05
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+13.04%
|
-
|
Apr 05
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
5,024
+10.83%
|
-
|
Apr 05
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,999
+14.08%
|
-
|
Mar 27
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
5,140
-12.39%
|
$87,380
$17.9 P/Share
|
Mar 27
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,434
-17.19%
|
$92,378
$17.9 P/Share
|
Mar 27
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
17,714
-12.97%
|
$301,138
$17.9 P/Share
|
Mar 25
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Grant, award, or other acquisition
|
Direct |
10,048
+19.5%
|
-
|
Mar 25
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,550
+25.02%
|
-
|
Mar 25
2024
|
Stephen Davis CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,666
+20.25%
|
-
|
Feb 26
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
624
-1.95%
|
$14,976
$24.67 P/Share
|
Feb 26
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
772
-3.54%
|
$18,528
$24.67 P/Share
|
Feb 26
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
474
-3.99%
|
$11,376
$24.67 P/Share
|
Feb 26
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
5,577
-5.19%
|
$133,848
$24.67 P/Share
|
Feb 23
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+3.34%
|
-
|